Sleep Spindles are scalp EEG waveforms that are hallmarks of the N2 sleep stage and are believed to be generated through thalamo-cortical loops. In this study we set out to study the interaction between cortical and subcortical regions involved in spindle activity using non-invasive measurements.

We present a general mechanistic model of mass diffusion for a composite sphere placed in a large ambient medium. The multi-layer problem is described by a system of diffusion equations coupled via interlayer boundary conditions such as those imposing a finite mass resistance at the extemal surface of the sphere. While the work is applicable to the generic problem of heat or mass transfer in a multi-layer sphere, the analysis and results are presented in the context of drug kinetics for desorbing and absorbing spherical microcapsules.

The nucleotides ATP and ADP regulate many aspects of endothelial cell (EC) biology, including intracellular calcium concentrations, focal adhesion activation, cytoskeletal organization, and cellular motility. In vivo, ECs are constantly under flow, and the concentration of ATP/ADP on the EC surface is determined by the combined effects of nucleotide convective and diffusive transport as well as hydrolysis by ectonucleotidases on the EC surface. In addition, experiments have demonstrated that flow induces ATP release from the cells.

We propose a novel in silico model for computing drug release from multi-layer capsules. The diffusion problem in such heterogeneous layer-by-layer composite medium is described by a system of coupled partial differential equations, which we solve analytically using separation of variables. In addition to the conventional partitioning and mass transfer interlayer conditions, we consider a surface finite mass transfer resistance, which corresponds to the case of a coated capsule.

In this study, we designed a novel drug-eluting coating for vascular implants consisting of a core coating of the anti-proliferative drug docetaxel ( DTX) and a shell coating of the platelet glycoprotein IIb/IIIa receptor monoclonal antibody SZ-21. The core/shell structure was sprayed onto the surface of 316L stainless steel stents using a coaxial electrospray process with the aim of creating a coating that exhibited a differential release of the two drugs. The prepared stents displayed a uniform coating consisting of nano/micro particles.

The topic of controlled drug release has received much attention in recent years, for example in the design of tablets and in local drug delivery devices such as stents, transdermal patches and orthopaedic implants. In recent years, we have developed a series of models for such devices to describe drug release from a polymeric platform and transport in surrounding biological tissues. These works have culminated in the development of a mathematical model that demonstrates agreement with in-vivo drug release and tissue uptake data, for the case of a drug-eluting stent.

Many drugs currently on the market or in development are poorly water-soluble. This presents a serious challenge to the pharmaceutical industry because orally delivered drugs that are poorly soluble tend to pass through the gastrointestinal tract before they can fully dissolve, leading to poor drug bioavailability. One strategy to improve drug solubility is to use a solid dispersion. A solid dispersion typically consists of a hydrophobic drug embedded in a hydrophilic polymer matrix.